tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Balaji Prasad, 23 are a SELL (12.37%), 15 are a HOLD (8.06%), 148 are a BUY (79.57%).
Analyst Balaji Prasad, currently employed at BARCLAYS, carries an average stock price target met ratio of 52.28% that have a potential upside of 21.94% achieved within 233 days.
Balaji Prasad’s has documented 381 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EOLS, Evolus at 04-Mar-2025.
Analyst best performing recommendations are on MNK (MALLINCKRODT PLC).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $123.52 was fulfilled within 1 day with a profit of $11.16 (9.93%) receiving and performance score of 99.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$10
$3.32 (49.70%)
$10
5 months 5 days ago
(01-May-2025)
12/25 (48%)
$4.58 (84.50%)
252
Hold
$8
$1.32 (19.76%)
$10
8 months 1 days ago
(05-Feb-2025)
1/4 (25%)
$1.46 (22.32%)
190
Sell
$3
$-3.68 (-55.09%)
$9
1 years 2 months 5 days ago
(01-Aug-2024)
11/14 (78.57%)
$-2.63 (-46.71%)
201
Hold
$7
$0.32 (4.79%)
1 years 2 months 12 days ago
(24-Jul-2024)
1/1 (100%)
$1.12 (19.05%)
53
Buy
$16
$9.32 (139.52%)
$9.5
2 years 17 days ago
(19-Sep-2023)
4/5 (80%)
$7.66 (91.85%)
143
What Year was the first public recommendation made by Balaji Prasad?
